Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Bacterial Infections and Mycoses

Free Subscription Articles published in J Antimicrob Chemother Retrieve available abstracts of 279 articles: HTML format Text format

Single Articles

March 2010
1. NIIMI K , Monk BC, Hirai A, Hatakenaka K, et al
   Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. SANDBERG A , Jensen KS, Baudoux P, Van Bambeke F, et al
   Intra- and extracellular activity of linezolid against Staphylococcus aureus in vivo and in vitro.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. LIAKOPOULOS A , Spiliopoulou I, Damani A, Kanellopoulou M, et al
   Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles   
   
   
   
4. YOON YK , Kim JY, Park DW, Sohn JW, et al
   Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
5. VAN DER PLAS MJ , Dambrot C, Dogterom-Ballering HC, Kruithof S, et al
   Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. EVANS J , Segal H
   Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. KLAASSEN CH , de Valk HA, Curfs-Breuker IM, Meis JF, et al
   Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. FESSLER A , Scott C, Kadlec K, Ehricht R, et al
   Characterization of methicillin-resistant Staphylococcus aureus ST398 from cases of bovine mastitis.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. GIANNOULI S , Labrou M, Kyritsis A, Ikonomidis A, et al
   Detection of mutations in the FemXAB protein family in oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates.
   J Antimicrob Chemother. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. ANGER HA , Dworkin F, Sharma S, Munsiff SS, et al
    Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. HEGDE SS , Skinner R, Lewis SR, Krause KM, et al
    Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. VANDENBOSCH D , Braeckmans K, Nelis HJ, Coenye T, et al
    Fungicidal activity of miconazole against Candida spp. biofilms.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. BOCHER S , Middendorf B, Westh H, Mellmann A, et al
    Semi-selective broth improves screening for methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. KIRBY A , Graham R, Williams NJ, Wootton M, et al
    Staphylococcus aureus with reduced glycopeptide susceptibility in Liverpool, UK.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
15. AHMAD Z , Nuermberger EL, Tasneen R, Pinn ML, et al
    Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. SYRE H , Ovreas K, Grewal HM
    Determination of the susceptibility of Mycobacterium tuberculosis to pyrazinamide in liquid and solid media assessed by a colorimetric nitrate reductase assay.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. ARDANUY C , Domenech A, Rolo D, Calatayud L, et al
    Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. MOISAN H , Pruneau M, Malouin F
    Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. HILL RL , Kearns AM, Nash J, North SE, et al
    Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patients.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. BORBONE S , Campanile F, Bongiorno D, Stefani S, et al
    In vitro bactericidal activity of ceftobiprole against hospital- and community-associated methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles   
    
    
    
21. ORTEGA M , Marco F, Soriano A, Almela M, et al
    Candida spp. bloodstream infection: influence of antifungal treatment on outcome.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. FERNANDEZ-HIDALGO N , Gavalda J, Almirante B, Martin MT, et al
    Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection.
    J Antimicrob Chemother. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
23. ELLINGTON MJ , Hope R, Livermore DM, Kearns AM, et al
    Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. PERDIGAO J , Macedo R, Malaquias A, Ferreira A, et al
    Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. GAUDREAU C , Lecours R, Ismail J, Gagnon S, et al
    Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
26. PARSONAGE M , Shah S, Moss P, Thaker H, et al
    Breakthrough bacteraemia with a susceptible Enterococcus faecalis during tigecycline monotherapy.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
27. ORR D , Wilkinson P, Moyce L, Martin S, et al
    Incidence and epidemiology of levofloxacin resistance in Streptococcus pneumoniae: experience from a tertiary referral hospital in England.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. KOFTERIDIS DP , Lewis RE, Kontoyiannis DP
    Caspofungin-non-susceptible Candida isolates in cancer patients.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. HUSSAIN A , Alleyne S, Jenkins D
    A survey of attitudes towards methicillin-resistant Staphylococcus aureus bacteraemias amongst United Kingdom microbiologists.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. TOBUDIC S , Kratzer C, Lassnigg A, Graninger W, et al
    In vitro activity of antifungal combinations against Candida albicans biofilms.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. STEIN GE , El-Mortada M, Smith C, Dybas L, et al
    Fungicidal activity of anidulafungin in serum from patients does not correlate to its susceptible breakpoint against Candida spp.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
32. HOOD JR , Burton D, Wilkinson JM, Cavanagh HM, et al
    Antifungal activity of Leptospermum petersonii oil volatiles against Aspergillus spp. in vitro and in vivo.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
33. IBRAHIM AS , Gebremariam T, French SW, Edwards JE Jr, et al
    The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. VAN DEN BOOGAARD J , Semvua HH, Boeree MJ, Aarnoutse RE, et al
    Sale of fluoroquinolones in northern Tanzania: a potential threat for fluoroquinolone use in tuberculosis treatment.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. ARANA DM , Nombela C, Pla J
    Fluconazole at subinhibitory concentrations induces the oxidative- and nitrosative-responsive genes TRR1, GRE2 and YHB1, and enhances the resistance of Candida albicans to phagocytes.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. OOI N , Miller K, Randall C, Rhys-Williams W, et al
    XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. KATO Y , Suzuki T, Ida T, Maebashi K, et al
    Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. ELLINGTON MJ , Ganner M, Warner M, Cookson BD, et al
    Polyclonal multiply antibiotic-resistant methicillin-resistant Staphylococcus aureus with Panton-Valentine leucocidin in England.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
39. NGUYEN HM , Graber CJ
    Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. LOZANO C , Lopez M, Gomez-Sanz E, Ruiz-Larrea F, et al
    Detection of methicillin-resistant Staphylococcus aureus ST398 in food samples of animal origin in Spain.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
41. VISCOLI C , Herbrecht R, Akan H, Baila L, et al
    An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. GOMEZ G DE LA PEDROSA E , Baquero F, Loza E, Nadal-Serrano JM, et al
    High clonal diversity in erythromycin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain (2000-07).
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. NAGANO N , Kimura K, Nagano Y, Yakumaru H, et al
    Molecular characterization of group B streptococci with reduced penicillin susceptibility recurrently isolated from a sacral decubitus ulcer.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
44. SOGE OO , Meschke JS, No DB, Roberts MC, et al
    Characterization of methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus spp. isolated from US West Coast public marine beaches.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. BIZZINI A , Zhao C, Auffray Y, Hartke A, et al
    The Enterococcus faecalis superoxide dismutase is essential for its tolerance to vancomycin and penicillin.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. FENOLL A , Gimenez MJ, Vicioso MD, Granizo JJ, et al
    Susceptibility of pneumococci causing meningitis in Spain and prevalence among such isolates of serotypes contained in the 7-valent pneumococcal conjugate vaccine.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
47. CHEN YH , Liu CY, Lu JJ, King CH, et al
    In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
48. KADLEC K , Ehricht R, Monecke S, Steinacker U, et al
    Diversity of antimicrobial resistance pheno- and genotypes of methicillin-resistant Staphylococcus aureus ST398 from diseased swine.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. DENIS O , Jans B, Deplano A, Nonhoff C, et al
    Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. RIJNDERS MI , Deurenberg RH, Boumans ML, Hoogkamp-Korstanje JA, et al
    Flucloxacillin, still the empirical choice for putative Staphylococcus aureus infections in intensive care units in the Netherlands.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. KOH WJ , Shim TS
    Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
52. BRINDLE R
    Has the publication of methicillin-resistant Staphylococcus aureus (MRSA) treatment guidelines increased the survival associated with MRSA bacteraemia?
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. DOYLE M , Feuerbaum EA, Fox KR, Hinds J, et al
    Response of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. SADER HS , Jones RN, Rossi KL, Rybak MJ, et al
    Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. MURILLO O , Pachon ME, Euba G, Verdaguer R, et al
    Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. DANDACHE P , Moise PA, Orsini J, Montecalvo M, et al
    Reduced biofilm production associated with increasing linezolid MICs among linezolid-resistant staphylococci.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
57. PEARSON A , Chronias A, Murray M
    Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England.
    J Antimicrob Chemother. 2009;64 Suppl 1:i11-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. BASSETTI M , Ansaldi F, Nicolini L, Malfatto E, et al
    Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
    J Antimicrob Chemother. 2009;64:625-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. SINGH R , Ledesma KR, Chang KT, Hou JG, et al
    Pharmacodynamics of moxifloxacin against a high inoculum of Escherichia coli in an in vitro infection model.
    J Antimicrob Chemother. 2009;64:556-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. NATHWANI D
    Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin.
    J Antimicrob Chemother. 2009;64:447-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. LAMOTH F , Buclin T, Pascual A, Calandra T, et al
    Imipenem underdosing as a cause of persistent neutropenic fever?
    J Antimicrob Chemother. 2009;64:665-7.
    PubMed     Text format     Related articles   
    
    
    
62. SCHINTLER MV , Traunmuller F, Metzler J, Kreuzwirt G, et al
    High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.
    J Antimicrob Chemother. 2009;64:574-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. HORSFIELD P , Deshpande S, Ellis R
    Killing with kindness? Drug reaction eosinophilia with systemic symptoms (DRESS) masquerading as acute severe sepsis.
    J Antimicrob Chemother. 2009;64:663-5.
    PubMed     Text format     Related articles   
    
    
    
64. CAI Y , Fan Y, Wang R, An MM, et al
    Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model.
    J Antimicrob Chemother. 2009;64:563-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. HITCHCOCK J , Jepson AP, Main J, Wickens HJ, et al
    Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series.
    J Antimicrob Chemother. 2009;64:630-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. ARDANUY C , Rolo D, Fenoll A, Tarrago D, et al
    Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.
    J Antimicrob Chemother. 2009;64:507-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. OTEO J , Cuevas O, Lopez-Rodriguez I, Banderas-Florido A, et al
    Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults.
    J Antimicrob Chemother. 2009;64:524-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. HAWKEY PM , Jones AM
    The changing epidemiology of resistance.
    J Antimicrob Chemother. 2009;64 Suppl 1:i3-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. LIVERMORE DM
    Has the era of untreatable infections arrived?
    J Antimicrob Chemother. 2009;64 Suppl 1:i29-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. HEAD M
    Infectious Disease Research Network.
    J Antimicrob Chemother. 2009;64 Suppl 1:i25-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. REYNOLDS R
    Antimicrobial resistance in the UK and Ireland.
    J Antimicrob Chemother. 2009;64 Suppl 1:i19-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
72. SIERRA JM , Ortega M, Tarrago C, Albet C, et al
    Decreased linezolid uptake in an in vitro-selected linezolid-resistant Staphylococcus epidermidis mutant.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. O'BRIEN FG , Coombs GW, Pearman JW, Gracey M, et al
    Population dynamics of methicillin-susceptible and -resistant Staphylococcus aureus in remote communities.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. VALVATNE H , Syre H, Kross M, Stavrum R, et al
    Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. IKAWA K , Nomura K, Morikawa N, Ikeda K, et al
    Assessment of micafungin regimens by pharmacokinetic-pharmacodynamic analysis: a dosing strategy for Aspergillus infections.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. CUI S , Li J, Hu C, Jin S, et al
    Isolation and characterization of methicillin-resistant Staphylococcus aureus from swine and workers in China.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. SHIKAMA MD , Silva RR, Martins MC, Giampaglia CM, et al
    Rapid detection of resistant tuberculosis by nitrate reductase assay performed in three settings in Brazil.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. YEW WW , Chang KC, Chau CH
    Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
79. SOTGIU G , Lange C, Richardson MD, Matteelli A, et al
    Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
80. YAN L , Li M, Cao Y, Gao P, et al
    The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. ARHIN FF , Sarmiento I, Parr TR Jr, Moeck G, et al
    Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
82. KOH WJ , Shim TS
    Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
83. POURNARAS S , Protonotariou E, Voulgari E, Kristo I, et al
    Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    J Antimicrob Chemother. 2009;64:348-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. EL SOLH AA , Alhajhusain A
    Update on the treatment of Pseudomonas aeruginosa pneumonia.
    J Antimicrob Chemother. 2009;64:229-38.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. GUPTA ND , Smith RE, Balakrishnan I
    Clinical efficacy of temocillin.
    J Antimicrob Chemother. 2009;64:431-3.
    PubMed     Text format     Related articles   
    
    
    
86. KOLVE H , Ahlke E, Fegeler W, Ritter J, et al
    Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation.
    J Antimicrob Chemother. 2009;64:383-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. JESPERSEN CM , Kolmos HJ, Frydendall N, Hilden J, et al
    Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial.
    J Antimicrob Chemother. 2009;64:411-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. HSIEH PH , Huang KC, Lee PC, Lee MS, et al
    Two-stage revision of infected hip arthroplasty using an antibiotic-loaded spacer: retrospective comparison between short-term and prolonged antibiotic therapy.
    J Antimicrob Chemother. 2009;64:392-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. GISKE CG , Ge J, Nordmann P
    Activity of cephalosporin CXA-101 (FR264205) and comparators against extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2009;64:430-1.
    PubMed     Text format     Related articles   
    
    
    
90. RODRIGUEZ I , Barownick W, Helmuth R, Mendoza MC, et al
    Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07.
    J Antimicrob Chemother. 2009;64:301-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. CLERMONT O , Dhanji H, Upton M, Gibreel T, et al
    Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains.
    J Antimicrob Chemother. 2009;64:274-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. WOLTER DJ , Black JA, Lister PD, Hanson ND, et al
    Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    J Antimicrob Chemother. 2009;64:294-300.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. MITJA O , Pigrau C, Ruiz I, Vidal X, et al
    Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study.
    J Antimicrob Chemother. 2009;64:416-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. CHISHOLM SA , Neal TJ, Alawattegama AB, Birley HD, et al
    Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales.
    J Antimicrob Chemother. 2009;64:353-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. KRISHNAN MY , Manning EJ, Collins MT
    Comparison of three methods for susceptibility testing of Mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs.
    J Antimicrob Chemother. 2009;64:310-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
96. MIRCUS G , Hagag S, Levdansky E, Sharon H, et al
    Identification of novel cell wall destabilizing antifungal compounds using a conditional Aspergillus nidulans protein kinase C mutant.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. SCHON T , Jureen P, Giske CG, Chryssanthou E, et al
    Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. TENOVER FC , Goering RV
    Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. NIENHOFF U , Kadlec K, Chaberny IF, Verspohl J, et al
    Transmission of methicillin-resistant Staphylococcus aureus strains between humans and dogs: two case reports.
    J Antimicrob Chemother. 2009.
    PubMed     Text format     Related articles   
    
    
    
100. TAZUMI A , Maeda Y, Goldsmith CE, Coulter WA, et al
     Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. LAZZELL AL , Chaturvedi AK, Pierce CG, Prasad D, et al
     Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. WU TS , Leu HS, Chiu CH, Lee MH, et al
     Clinical manifestations, antibiotic susceptibility and molecular analysis of Mycobacterium kansasii isolates from a university hospital in Taiwan.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. BERGVAL IL , Schuitema AR, Klatser PR, Anthony RM, et al
     Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. PATEL SN , Pillai DR, Pong-Porter S, McGeer A, et al
     In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
105. MCCRACKEN M , Decorby M, Fuller J, Loo V, et al
     Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. KINANA AD , Ricci V, Piddock LJ
     Contribution of efflux to antibiotic resistance in Campylobacter isolated from poultry in Senegal.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
107. VOULOUMANOU EK , Karageorgopoulos DE, Kazantzi MS, Kapaskelis AM, et al
     Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials.
     J Antimicrob Chemother. 2009;64:16-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. MORRISSEY I , Biek D, Janes R
     ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia.
     J Antimicrob Chemother. 2009;64:209-10.
     PubMed     Text format     Related articles   
     
     
     
109. LAMONT E , Seaton RA, Macpherson M, Semple L, et al
     Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme.
     J Antimicrob Chemother. 2009;64:181-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. THOMPSON GR 3RD , Wiederhold NP, Sutton DA, Fothergill A, et al
     In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species.
     J Antimicrob Chemother. 2009;64:79-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. KRUGER S , Ewig S, Kunde J, Hanschmann A, et al
     C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ.
     J Antimicrob Chemother. 2009;64:159-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. MERTZ D , Koller M, Haller P, Lampert ML, et al
     Outcomes of early switching from intravenous to oral antibiotics on medical wards.
     J Antimicrob Chemother. 2009;64:188-99.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. ROBERTS JA , Kirkpatrick CM, Roberts MS, Robertson TA, et al
     Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
     J Antimicrob Chemother. 2009;64:142-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. LAI CC , Tan CK, Lin SH, Liao CH, et al
     Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.
     J Antimicrob Chemother. 2009;64:73-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. KOUDA S , Ohara M, Onodera M, Fujiue Y, et al
     Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima.
     J Antimicrob Chemother. 2009;64:46-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. TOUATI E , Michel V, Correia M, Menghini L, et al
     Boropinic acid, a novel inhibitor of Helicobacter pylori stomach colonization.
     J Antimicrob Chemother. 2009;64:210-1.
     PubMed     Text format     Related articles   
     
     
     
117. COENEN S , Muller A, Adriaenssens N, Vankerckhoven V, et al
     European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe.
     J Antimicrob Chemother. 2009;64:200-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2009
118. GONZALEZ GM , Portillo OJ, Uscanga GI, Andrade SE, et al
     Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. O'SHEA S , Cotter L, Creagh S, Lydon S, et al
     Mupirocin resistance among staphylococci: trends in the southern region of Ireland.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
120. BEETON ML , Chalker VJ, Kotecha S, Spiller OB, et al
     Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. PIPER C , Draper LA, Cotter PD, Ross RP, et al
     A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. POTRON A , Poirel L, Bernabeu S, Monnet X, et al
     Nosocomial spread of ESBL-positive Enterobacter cloacae co-expressing plasmid-mediated quinolone resistance Qnr determinants in one hospital in France.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
123. ROONEY PJ , O'Leary MC, Loughrey AC, McCalmont M, et al
     Nursing homes as a reservoir of extended-spectrum {beta}-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. DE VRIES LE , Christensen H, Skov RL, Aarestrup FM, et al
     Diversity of the tetracycline resistance gene tet(M) and identification of Tn916- and Tn5801-like (Tn6014) transposons in Staphylococcus aureus from humans and animals.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. BOLOTIN S , Alexander DC, Chedore P, Drews SJ, et al
     Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. SU LH , Wu TL, Kuo AJ, Chia JH, et al
     Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000-07: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. HAUCK Y , Fabre M, Vergnaud G, Soler C, et al
     Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. VERNAZ N , Hill K, Leggeat S, Nathwani D, et al
     Temporal effects of antibiotic use and Clostridium difficile infections.
     J Antimicrob Chemother. 2009;63:1272-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. GELFAND MS , Cleveland KO, Mazumder SA
     Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
     J Antimicrob Chemother. 2009;63:1297-9.
     PubMed     Text format     Related articles   
     
     
     
130. STARNINO S , Stefanelli P
     Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy.
     J Antimicrob Chemother. 2009;63:1200-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. BLANCO M , Alonso MP, Nicolas-Chanoine MH, Dahbi G, et al
     Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
     J Antimicrob Chemother. 2009;63:1135-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. BYREN I , Bejon P, Atkins BL, Angus B, et al
     One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome.
     J Antimicrob Chemother. 2009;63:1264-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. ARPIN C , Quentin C, Grobost F, Cambau E, et al
     Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
     J Antimicrob Chemother. 2009;63:1205-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. AZOR M , Cano J, Gene J, Guarro J, et al
     High genetic diversity and poor in vitro response to antifungals of clinical strains of Fusarium oxysporum.
     J Antimicrob Chemother. 2009;63:1152-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. GUILLOUZOUIC A , Caroff N, Dauvergne S, Lepelletier D, et al
     MLST typing of Escherichia coli isolates overproducing AmpC {beta}-lactamase.
     J Antimicrob Chemother. 2009;63:1290-2.
     PubMed     Text format     Related articles   
     
     
     May 2009
136. KOH WJ , Kwon OJ, Gwak H, Chung JW, et al
     Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. NAGASAKI Y , Eriguchi Y, Uchida Y, Miyake N, et al
     Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. BRATU S , Landman D, George A, Salvani J, et al
     Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. EVANS MR , Northey G, Sarvotham TS, Hopkins AL, et al
     Risk factors for ciprofloxacin-resistant Campylobacter infection in Wales.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. CUIROLO A , Plata K, Rosato AE
     Development of homogeneous expression of resistance in methicillin-resistant Staphylococcus aureus clinical strains is functionally associated with a {beta}-lactam-mediated SOS response.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. TAN CK , Lai CC, Liao CH, Chou CH, et al
     Comparative in vitro activities of the new quinolone nemonoxacin (TG-873870), gemifloxacin and other quinolones against clinical isolates of Mycobacterium tuberculosis.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
142. ZHANEL GG , Voth D, Nichol K, Karlowsky JA, et al
     Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro mode
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. SUNDQVIST M , Kahlmeter G
     'Pre-emptive culturing' will improve the chance of 'getting it right' when empirical therapy of urinary tract infections fails.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. COATES T , Bax R, Coates A
     Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. AL-HASAN MN , Lahr BD, Eckel-Passow JE, Baddour LM, et al
     Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. LIAKOPOULOS A , Neocleous C, Klapsa D, Kanellopoulou M, et al
     A T2504A mutation in the 23S rRNA gene responsible for high-level resistance to linezolid of Staphylococcus epidermidis.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
147. BUKH AS , Schonheyder HC, Emmersen JM, Sogaard M, et al
     Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. MAVE V , Garcia-Diaz J, Islam T, Hasbun R, et al
     Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. HOPE CK , Packer S, Wilson M, Nair SP, et al
     The inability of a bacteriophage to infect Staphylococcus aureus does not prevent it from specifically delivering a photosensitizer to the bacterium enabling its lethal photosensitization.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. SINKO J , Kullberg BJ, Edwards JE, Anaissie E, et al
     The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.
     J Antimicrob Chemother. 2009;63 Suppl 1:i41-3.
     PubMed     Text format     Related articles   
     
     
     
151. VERWEIJ PE , Maertens J
     The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Moulds: diagnosis and treatment.
     J Antimicrob Chemother. 2009;63 Suppl 1:i31-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. BODEY GP
     The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years.
     J Antimicrob Chemother. 2009;63 Suppl 1:i3-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. MASCHMEYER G
     The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.
     J Antimicrob Chemother. 2009;63 Suppl 1:i27-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. BENNETT JE
     The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Management of mycoses in neutropenic patients: a brief history, 1960-2008.
     J Antimicrob Chemother. 2009;63 Suppl 1:i23-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. MEIS JF
     The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Moulds and man.
     J Antimicrob Chemother. 2009;63 Suppl 1:i21-2.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. WILLIAMS KJ
     The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why monotherapy?
     J Antimicrob Chemother. 2009;63 Suppl 1:i18-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. PIZZO PA
     The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Where do we go from here?
     J Antimicrob Chemother. 2009;63 Suppl 1:i16-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. KLASTERSKY J
     The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
     J Antimicrob Chemother. 2009;63 Suppl 1:i14-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. THOMSON AH , Staatz CE, Tobin CM, Gall M, et al
     Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.
     J Antimicrob Chemother. 2009;63:1050-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. BEGG EJ , Vella-Brincat JW, Robertshawe B, McMurtrie MJ, et al
     Eight years' experience of an extended-interval dosing protocol for gentamicin in neonates.
     J Antimicrob Chemother. 2009;63:1043-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. LIU W , Chen L, Li H, Duan H, et al
     Novel CTX-M {beta}-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China.
     J Antimicrob Chemother. 2009;63:895-900.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. TESSMER A , Welte T, Martus P, Schnoor M, et al
     Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.
     J Antimicrob Chemother. 2009;63:1025-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. KOOMANACHAI P , Kim A, Nicolau DP
     Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.
     J Antimicrob Chemother. 2009;63:982-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. PELLEGRINI C , Mercuri PS, Celenza G, Galleni M, et al
     Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location.
     J Antimicrob Chemother. 2009;63:901-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. LESPRIT P , Duong T, Girou E, Hemery F, et al
     Impact of a computer-generated alert system prompting review of antibiotic use in hospitals.
     J Antimicrob Chemother. 2009;63:1058-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. KEULEYAN EE , Kirilov KG
     Comment on: Aminoglycoside drugs in clinical practice: an evidence-based approach.
     J Antimicrob Chemother. 2009;63:1081-2.
     PubMed     Text format     Related articles   
     
     
     
167. OCHSNER UA , Bell SJ, O'Leary AL, Hoang T, et al
     Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.
     J Antimicrob Chemother. 2009;63:964-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. KUO CH , Hu HM, Kuo FC, Hsu PI, et al
     Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial.
     J Antimicrob Chemother. 2009;63:1017-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. CALS JW
     Comment on: The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance.
     J Antimicrob Chemother. 2009;63:1083-4.
     PubMed     Text format     Related articles   
     
     
     
170. HAMES A , Perry JD, Gould FK
     In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile.
     J Antimicrob Chemother. 2009;63:1076.
     PubMed     Text format     Related articles   
     
     
     
171. BOGAERTS P , Rodriguez-Villalobos H, Laurent C, Deplano A, et al
     Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals.
     J Antimicrob Chemother. 2009;63:1073-5.
     PubMed     Text format     Related articles   
     
     
     April 2009
172. KOKAI-KUN JF , Chanturiya T, Mond JJ
     Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. VICKERS AA , Potter NJ, Fishwick CW, Chopra I, et al
     Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. PIETZKA AT , Indra A, Stoger A, Zeinzinger J, et al
     Rapid identification of multidrug-resistant Mycobacterium tuberculosis isolates by rpoB gene scanning using high-resolution melting curve PCR analysis.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. JENKINS C , Bacon J, Allnutt J, Hatch KA, et al
     Enhanced heterogeneity of rpoB in Mycobacterium tuberculosis found at low pH.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. MCKAY GA , Beaulieu S, Arhin FF, Belley A, et al
     Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. YIANNAKOPOULOU ECH
     Methodological issues regarding safety evaluation in randomized controlled trials of the effectiveness of antibiotic prophylaxis for the prevention of post-operative wound infection: systematic review.
     J Antimicrob Chemother. 2009;63:843-5.
     PubMed     Text format     Related articles   
     
     
     
178. JENSEN US , Skjot-Rasmussen L, Olsen SS, Frimodt-Moller N, et al
     Consequences of increased antibacterial consumption and change in pattern of antibacterial use in Danish hospitals.
     J Antimicrob Chemother. 2009;63:812-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. FINCH R , Sharland M
     18 November and beyond: observations on the EU Antibiotic Awareness Day.
     J Antimicrob Chemother. 2009;63:633-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. RODRIGUEZ-BANO J , Alcala J, Cisneros JM, Grill F, et al
     Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
     J Antimicrob Chemother. 2009;63:781-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. SAMUELSEN O , Naseer U, Tofteland S, Skutlaberg DH, et al
     Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
     J Antimicrob Chemother. 2009;63:654-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. KOLDITZ M , Bickhardt J, Matthiessen W, Holotiuk O, et al
     Medical management of pulmonary actinomycosis: data from 49 consecutive cases.
     J Antimicrob Chemother. 2009;63:839-41.
     PubMed     Text format     Related articles   
     
     
     
183. NAQVI SM , Jenkins C, McHugh TD, Balakrishnan I, et al
     Identification of the qnr family in Enterobacteriaceae in clinical practice.
     J Antimicrob Chemother. 2009;63:830-2.
     PubMed     Text format     Related articles   
     
     
     
184. LECAILLET A , Mallet MN, Raoult D, Rolain JM, et al
     Therapeutic impact of the correlation of doxycycline serum concentrations and the decline of phase I antibodies in Q fever endocarditis.
     J Antimicrob Chemother. 2009;63:771-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. REGULA G , Torriani K, Gassner B, Stucki F, et al
     Prescription patterns of antimicrobials in veterinary practices in Switzerland.
     J Antimicrob Chemother. 2009;63:805-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. SCHEETZ MH , Bolon MK, Postelnick M, Noskin GA, et al
     Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis.
     J Antimicrob Chemother. 2009;63:816-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. LAU SK , Wong GK, Poon RW, Lee LC, et al
     Susceptibility patterns of clinical and fish isolates of Laribacter hongkongensis: comparison of the Etest, disc diffusion and broth microdilution methods.
     J Antimicrob Chemother. 2009;63:704-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. MONTRAVERS P , Lepape A, Dubreuil L, Gauzit R, et al
     Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study.
     J Antimicrob Chemother. 2009;63:785-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. WUEPPENHORST N , Stueger HP, Kist M, Glocker E, et al
     Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.
     J Antimicrob Chemother. 2009;63:648-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. GORDON NC , Wareham DW
     A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline.
     J Antimicrob Chemother. 2009;63:775-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2009
191. DEVASIA RA , Blackman A, May C, Eden S, et al
     Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. FREITAS AR , Novais C, Ruiz-Garbajosa P, Coque TM, et al
     Clonal expansion within clonal complex 2 and spread of vancomycin-resistant plasmids among different genetic lineages of Enterococcus faecalis from Portugal.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
193. BERNAL P , Zloh M, Taylor PW
     Disruption of D-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the {beta}-lactam resistance modifier (-)-epicatechin gallate.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. EL GARCH F , Hallin M, De Mendonca R, Denis O, et al
     StaphVar-DNA microarray analysis of accessory genome elements of community-acquired methicillin-resistant Staphylococcus aureus.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. BEGIC D , von Eiff C, Tsuji BT
     Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. PU XY , Pan JC, Wang HQ, Zhang W, et al
     Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
197. GOULD FK , Brindle R, Chadwick PR, Fraise AP, et al
     Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
198. SAUER K , Steczko J, Ash SR
     Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
199. MALHOTRA-KUMAR S , Van Heirstraeten L, Lammens C, Chapelle S, et al
     Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
200. REHM S , Campion M, Katz DE, Russo R, et al
     Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
201. MOISE PA , Smyth DS, Robinson DA, El-Fawal N, et al
     Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studies.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
202. SEGUIN P , Verdier MC, Chanavaz C, Engrand C, et al
     Plasma and peritoneal concentration following continuous infusion of cefotaxime in patients with secondary peritonitis.
     J Antimicrob Chemother. 2009;63:564-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
203. ANNALORO C , Olivares C, Usardi P, Onida F, et al
     Retrospective evaluation of amphotericin B deoxycholate toxicity in a single centre series of haematopoietic stem cell transplantation recipients.
     J Antimicrob Chemother. 2009;63:625-6.
     PubMed     Text format     Related articles   
     
     
     
204. DERBYSHIRE H , Kay G, Evans K, Vaughan C, et al
     A simple disc diffusion method for detecting AmpC and extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae.
     J Antimicrob Chemother. 2009;63:497-501.
     PubMed     Text format     Related articles    Abstract available
     
     
     
205. ENDIMIANI A , Hujer AM, Perez F, Bethel CR, et al
     Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.
     J Antimicrob Chemother. 2009;63:427-37.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. PUGLIESE N , Maimone F, Scrascia M, Materu SF, et al
     SXT-related integrating conjugative element and IncC plasmids in Vibrio cholerae O1 strains in Eastern Africa.
     J Antimicrob Chemother. 2009;63:438-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
207. JARURATANASIRIKUL S , Sudsai T
     Comparison of the pharmacodynamics of imipenem in patients with ventilator-associated pneumonia following administration by 2 or 0.5 h infusion.
     J Antimicrob Chemother. 2009;63:560-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. AMARAL AC , Bocca AL, Ribeiro AM, Nunes J, et al
     Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis.
     J Antimicrob Chemother. 2009;63:526-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. KAIER K , Frank U, Hagist C, Conrad A, et al
     The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum beta-lactamase-producing strains: a time-series analysis.
     J Antimicrob Chemother. 2009;63:609-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
210. AOKI N , Tateda K, Kikuchi Y, Kimura S, et al
     Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
     J Antimicrob Chemother. 2009;63:534-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
211. STOEVA T , Higgins PG, Savov E, Markovska R, et al
     Nosocomial spread of OXA-23 and OXA-58 beta-lactamase-producing Acinetobacter baumannii in a Bulgarian hospital.
     J Antimicrob Chemother. 2009;63:618-20.
     PubMed     Text format     Related articles   
     
     
     
212. MACHADO E , Coque TM, Canton R, Sousa JC, et al
     Leakage into Portuguese aquatic environments of extended-spectrum-beta-lactamase-producing Enterobacteriaceae.
     J Antimicrob Chemother. 2009;63:616-8.
     PubMed     Text format     Related articles   
     
     
     February 2009
213. MUGNIER PD , Bindayna KM, Poirel L, Nordmann P, et al
     Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
214. AMMERLAAN HS , Troelstra A, Kruitwagen CL, Kluytmans JA, et al
     Quantifying changes in incidences of nosocomial bacteraemia caused by antibiotic-susceptible and antibiotic-resistant pathogens.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. BERESFORD NJ , Mulhearn D, Szczepankiewicz B, Liu G, et al
     Inhibition of MptpB phosphatase from Mycobacterium tuberculosis impairs mycobacterial survival in macrophages.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
216. NILSSON O , Greko C, Top J, Franklin A, et al
     Spread without known selective pressure of a vancomycin-resistant clone of Enterococcus faecium among broilers.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. SKOV R , Smyth R, Yusof A, Karlsson A, et al
     Effects of temperature on the detection of methicillin resistance in Staphylococcus aureus using cefoxitin disc diffusion testing with Iso-Sensitest agar.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
218. DASKALAKI M , Otero JR, Chaves F
     Molecular characterization of resistance to mupirocin in methicillin-resistant Staphylococcus aureus isolates in a tertiary hospital in Spain.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
219. GIANNOULI M , Tomasone F, Agodi A, Vahaboglu H, et al
     Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
220. DUDDY NE , Moore CB, Howard SJ, Denning DW, et al
     In vitro susceptibility of non-Aspergillus allergenic fungal species to azoles.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
221. HO PL , Cheng VC, Chow KH
     Decreasing prevalence of levofloxacin-resistant Streptococcus pneumoniae in Hong Kong, 2001 to 2007.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
222. DE VECCHI E , Nicola L, Ossola F, Drago L, et al
     In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
223. OEFNER C , Bandera M, Haldimann A, Laue H, et al
     Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
224. GILLHAM MI , Sundaram S, Laughton CR, Haworth CS, et al
     Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
225. BAGLIONI P
     Comment on: Urinary tract infection in hospitalized elderly patients in the United Kingdom: the importance of making an accurate diagnosis in the post broad-spectrum antibiotic era.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
226. PATZER JA , Walsh TR, Weeks J, Dzierzanowska D, et al
     Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006.
     J Antimicrob Chemother. 2009;63:269-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
227. LIVERMORE DM , Tulkens PM
     Temocillin revived.
     J Antimicrob Chemother. 2009;63:243-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
228. KOFOED K , Zalounina A, Andersen O, Lisby G, et al
     Performance of the TREAT decision support system in an environment with a low prevalence of resistant pathogens.
     J Antimicrob Chemother. 2009;63:400-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
229. DOUBLET B , Praud K, Weill FX, Cloeckaert A, et al
     Association of IS26-composite transposons and complex In4-type integrons generates novel multidrug resistance loci in Salmonella genomic island 1.
     J Antimicrob Chemother. 2009;63:282-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
230. BEAN DC , Wareham DW
     Paradoxical effect of 1-(1-naphthylmethyl)-piperazine on resistance to tetracyclines in multidrug-resistant Acinetobacter baumannii.
     J Antimicrob Chemother. 2009;63:349-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
231. SORIANO F , Huelves L, Naves P, Rodriguez-Cerrato V, et al
     In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
     J Antimicrob Chemother. 2009;63:353-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
232. TORPDAHL M , Hammerum AM, Zachariasen C, Nielsen EM, et al
     Detection of qnr genes in Salmonella isolated from humans in Denmark.
     J Antimicrob Chemother. 2009;63:406-8.
     PubMed     Text format     Related articles   
     
     
     
233. RODRIGUEZ MM , Pastor FJ, Serena C, Guarro J, et al
     Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
     J Antimicrob Chemother. 2009;63:361-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
234. RANDALL LP , Kirchner M, Teale CJ, Coldham NG, et al
     Evaluation of CHROMagar CTX, a novel medium for isolating CTX-M-ESBL-positive Enterobacteriaceae while inhibiting AmpC-producing strains.
     J Antimicrob Chemother. 2009;63:302-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
235. BLONDEAU JM
     What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?
     J Antimicrob Chemother. 2009;63:238-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
236. PEIRANO G , Seki LM, Val Passos VL, Pinto MC, et al
     Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
     J Antimicrob Chemother. 2009;63:265-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
237. LEIBOVICI L , Vidal L, Paul M
     Aminoglycoside drugs in clinical practice: an evidence-based approach.
     J Antimicrob Chemother. 2009;63:246-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
238. LLOR C , Sierra N, Hernandez S, Moragas A, et al
     The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance.
     J Antimicrob Chemother. 2009;63:396-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
239. BARLOW M , Fatollahi J, Salverda M
     Evidence for recombination among the alleles encoding TEM and SHV beta-lactamases.
     J Antimicrob Chemother. 2009;63:256-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
240. GARCIA-FERNANDEZ A , Fortini D, Veldman K, Mevius D, et al
     Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella.
     J Antimicrob Chemother. 2009;63:274-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
241. LU PL , Doumith M, Livermore DM, Chen TP, et al
     Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
242. HARRISON CJ , Woods C, Stout G, Martin B, et al
     Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
243. LIVERMORE DM , Mushtaq S, Warner M, Woodford N, et al
     Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
244. HEGDE SS , Difuntorum S, Skinner R, Trumbull J, et al
     Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
245. WIERZBOWSKI AK , Karlowsky JA, Hoban DJ, Zhanel GG, et al
     In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
246. SHANSON DC
     Comment on: New guidance from NICE regarding antibiotic prophylaxis for infective endocarditis - response by the BSAC Working Party.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles   
     
     
     
247. CAMBAU E , Matrat S, Pan XS, Bettoni RR, et al
     Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
248. KADRY AA , Fouda SI, Shibl AM, Abu El-Asrar AA, et al
     Impact of slime dispersants and anti-adhesives on in vitro biofilm formation of Staphylococcus epidermidis on intraocular lenses and on antibiotic activities.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
249. JOHN MA , Burden J, Stuart JI, Reyes RC, et al
     Comparison of three phenotypic techniques for detection of methicillin resistance in Staphylococcus spp. reveals a species-dependent performance.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
250. LEONARD SN , Rossi KL, Newton KL, Rybak MJ, et al
     Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
251. ORTEGA M , Marco F, Soriano A, Almela M, et al
     Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
     J Antimicrob Chemother. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
252. GOULD IM
     Comment on: Interventions to control MRSA: high time for time-series analysis?
     J Antimicrob Chemother. 2009;63:224.
     PubMed     Text format     Related articles   
     
     
     
253. SUZUKI S , Shibata N, Yamane K, Wachino J, et al
     Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread.
     J Antimicrob Chemother. 2009;63:72-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
254. AL-BADRIYEH D , Liew D, Stewart K, Kong DC, et al
     Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia.
     J Antimicrob Chemother. 2009;63:197-208.
     PubMed     Text format     Related articles    Abstract available
     
     
     
255. DIESTRA K , Juan C, Curiao T, Moya B, et al
     Characterization of plasmids encoding blaESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae.
     J Antimicrob Chemother. 2009;63:60-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
256. CUI S , Li J, Sun Z, Hu C, et al
     Characterization of Salmonella enterica isolates from infants and toddlers in Wuhan, China.
     J Antimicrob Chemother. 2009;63:87-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
257. SUNDE M , Tharaldsen H, Slettemeas JS, Norstrom M, et al
     Escherichia coli of animal origin in Norway contains a blaTEM-20-carrying plasmid closely related to blaTEM-20 and blaTEM-52 plasmids from other European countries.
     J Antimicrob Chemother. 2009;63:215-6.
     PubMed     Text format     Related articles   
     
     
     
258. MENDES RE , Bell JM, Turnidge JD, Castanheira M, et al
     Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
     J Antimicrob Chemother. 2009;63:55-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
259. PEA F , Viale P, Lugano M, Baccarani U, et al
     Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients.
     J Antimicrob Chemother. 2009;63:167-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
260. EDGAR T , Boyd SD, Palame MJ
     Sustainability for behaviour change in the fight against antibiotic resistance: a social marketing framework.
     J Antimicrob Chemother. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
261. WU JJ , Ko WC, Chiou CS, Chen HM, et al
     Emergence of Qnr determinants in human Salmonella isolates in Taiwan.
     J Antimicrob Chemother. 2008;62:1269-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
262. HALWANI M , Yebio B, Suntres ZE, Alipour M, et al
     Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
     J Antimicrob Chemother. 2008;62:1291-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
263. POUDYAL A , Howden BP, Bell JM, Gao W, et al
     In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae.
     J Antimicrob Chemother. 2008;62:1311-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
264. HACHEM RY , Langston AA, Graybill JR, Perfect JR, et al
     Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment.
     J Antimicrob Chemother. 2008;62:1386-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
265. MORINAGA Y , Yanagihara K, Nakamura S, Yamamoto K, et al
     In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
     J Antimicrob Chemother. 2008;62:1326-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
266. WOODFORD N , Zhang J, Kaufmann ME, Yarde S, et al
     Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
     J Antimicrob Chemother. 2008;62:1265-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
267. WOODFORD N , Zhang J, Warner M, Kaufmann ME, et al
     Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom.
     J Antimicrob Chemother. 2008;62:1261-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
268. PATERSON DL , David K, Mrsic M, Cetkovsky P, et al
     Pre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry.
     J Antimicrob Chemother. 2008;62:1392-400.
     PubMed     Text format     Related articles    Abstract available
     
     
     
269. CIRIONI O , Silvestri C, Ghiselli R, Orlando F, et al
     Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.
     J Antimicrob Chemother. 2008;62:1332-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
270. MEYER E , Gastmeier P, Schwab F
     The burden of multiresistant bacteria in German intensive care units.
     J Antimicrob Chemother. 2008;62:1474-6.
     PubMed     Text format     Related articles   
     
     
     
271. LAU SH , Kaufmann ME, Livermore DM, Woodford N, et al
     UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone.
     J Antimicrob Chemother. 2008;62:1241-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
272. KUSTER SP , Ruef C, Zbinden R, Gottschalk J, et al
     Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay.
     J Antimicrob Chemother. 2008;62:1451-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
273. TSAKRIS A , Kristo I, Poulou A, Markou F, et al
     First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests.
     J Antimicrob Chemother. 2008;62:1257-60.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
274. MCMURDO ME , Argo I, Phillips G, Daly F, et al
     Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women.
     J Antimicrob Chemother. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
275. WU CM , Wang Y, Cao XY, Lin JC, et al
     Emergence of plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolated from chickens in China.
     J Antimicrob Chemother. 2008.
     PubMed     Text format     Related articles   
     
     
     
276. GOPAL RAO G , Patel M
     Urinary tract infection in hospitalized elderly patients in the United Kingdom: the importance of making an accurate diagnosis in the post broad-spectrum antibiotic era.
     J Antimicrob Chemother. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
277. WEI Q , Jiang X, Yang Z, Chen N, et al
     dfrA27, a new integron-associated trimethoprim resistance gene from Escherichia coli.
     J Antimicrob Chemother. 2008.
     PubMed     Text format     Related articles   
     
     
     
278. MAK JK , Kim MJ, Pham J, Tapsall J, et al
     Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii.
     J Antimicrob Chemother. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
279. JONES GL , Warren RE, Skidmore SJ, Davies VA, et al
     Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum {beta}-lactamases.
     J Antimicrob Chemother. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: